Horizon Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
395
-2,914
-88% -$1.34M ﹤0.01% 1005
2026
Q1
$1.59M Sell
3,309
-5,465
-62% -$2.8M 0.02% 540
2025
Q4
$4.93M Buy
+8,774
New +$4.98M 0.06% 248
2024
Q3
– Sell
-3
Closed -$1.24K – 865
2024
Q2
$1.24K Hold
3
– – ﹤0.01% 729
2024
Q1
$1.21K Buy
3
+2
+200% +$703 ﹤0.01% 723
2023
Q4
$307 Hold
1
– – ﹤0.01% 789
2023
Q3
$242 Hold
1
– – ﹤0.01% 769
2023
Q2
$240 Buy
+1
New +$208 ﹤0.01% 745

Other funds holding MEDP

Horizon Investments's MEDP Position: Q2 2026 in Review

Horizon Investments reduced its Medpace (MEDP) stake by 88% in Q2 2026, selling an estimated $1.34M and leaving 395 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Horizon Investments first reported a position in MEDP in Q2 2023 and has held it in 8 quarters since. The position peaked at $4.93M in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Horizon Investments held 395 shares of Medpace worth $209K as of Q2 2026.
  • Horizon Investments sold 2,914 Medpace shares in Q2 2026, an estimated $1.34M.
  • Medpace made up ﹤0.01% of Horizon Investments's portfolio in Q2 2026, its #1005 holding.
  • Horizon Investments first reported a position in Medpace in Q2 2023 and has held it in 8 quarters since.
  • Horizon Investments's Medpace position peaked at $4.93M in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.